Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Adma Biologics Inc’s stock clocked out at $15.88, down -4.68% from its previous closing price of $16.66. In other words, the price has decreased by -$4.68 from its previous closing price. On the day, 1.77 million shares were traded. ADMA stock price reached its highest trading level at $16.83 during the session, while it also had its lowest trading level at $15.85.
Ratios:
To gain a deeper understanding of ADMA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 43.29 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 47.28. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 22 ’24 when Tade Brad L. sold 15,000 shares for $21.15 per share. The transaction valued at 317,250 led to the insider holds 199,433 shares of the business.
Grossman Adam S sold 48,967 shares of ADMA for $1,033,204 on Nov 22 ’24. The President and CEO now owns 1,989,007 shares after completing the transaction at $21.10 per share. On Nov 22 ’24, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 48,967 shares for $21.30 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 3753873152 and an Enterprise Value of 3778554112. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 57.47, and their Forward P/E ratio for the next fiscal year is 22.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.81 while its Price-to-Book (P/B) ratio in mrq is 16.19. Its current Enterprise Value per Revenue stands at 9.871 whereas that against EBITDA is 30.014.
Stock Price History:
The Beta on a monthly basis for ADMA is 0.60, which has changed by 2.1257036 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $5.02. The 50-Day Moving Average of the stock is -10.51%, while the 200-Day Moving Average is calculated to be 3.42%.
Shares Statistics:
It appears that ADMA traded 2.55M shares on average per day over the past three months and 2247180 shares per day over the past ten days. A total of 236.38M shares are outstanding, with a floating share count of 227.35M. Insiders hold about 3.82% of the company’s shares, while institutions hold 90.00% stake in the company. Shares short for ADMA as of 1738281600 were 13176851 with a Short Ratio of 5.31, compared to 1735603200 on 13622817. Therefore, it implies a Short% of Shares Outstanding of 13176851 and a Short% of Float of 5.74.
